Hospital Acquired Infections Market Size, Competitive Landscape and Market Forecast - 2029

SKU: DMMD429 | Last Updated On: Sep 20 2022 | Available Formats

> Global Hospital Acquired Infections Market Expected to reach at a high CAGR by 2029: DataM Intelligence

Global Hospital Acquired Infections Market is segmented by Infection Type (Ventilator Associated Pneumonia, Urinary Tract Infections, Surgical Site Infections, Bloodstream Infections, Others (Gastrointestinal, ENT, Skin, Bone Infections)), By Treatment Type (Antiviral Treatment (Acyclovir, Foscarnet), Antibacterial Treatment (Vancomycin, Beta-Lactams, Quinolones, Others), Antifungal Treatment (Amphotericin B, Triazoles), Others (Antiparasitic, Antiprotozoal, Anti-TB Treatment)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029


Market Overview

[150 Pages Report] The Global Hospital Acquired Infections Market is expected to grow at a high CAGR during the forecasting period (2022-2029).

Hospital Acquired Infections Market - Strategic Insights



Market CAGR


Segments Covered

By Infection Type, By Treatment Type, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To Get a Free Sample Click here

Hospital-acquired infections (HAI), or nosocomial infections, are acquired in a hospital or other healthcare facilities.

Market Dynamics:

  • The most common factor causing the growth of the hospital-acquired infection market is the growing elderly population globally as the elderly population is more prone to infections due to their low physical immunity.

  • Moreover, the low level of hygiene in hospitals, poor infrastructure management, and poor sterilizing techniques used at healthcare institutions are consequently increasing the number of hospital-acquired infection cases.

  • National 2015 Standardized Infection Ratios (SIRs) Calculated

  • HAI Type Hospitals Predicted Infection

  • Catheter-associated Urinary Tract Infection (CAUTI) 4,165 27,029

  • Central Line-associated Bloodstream Infection (CLABSI) 3,935 27,313

  • Surgical Site Infection (SSI)- Abdominal Hysterectomy 3,248 2,091

  • MRSA Bacteremia LabID Event 4,035 8,898

  • Surgical Site Infection (SSI) – Colon Surgery 3,395 9,280

  • Increasing incidences of different types of hospital-acquired infection, advancement in technologies implemented in devices that control infection are some of the growth factors boosting the HAI market.

  • However, lack of awareness towards hospital-acquired infections, and increasing use of outpatient treatment are hindering the growth of the market.

Market Segmentation:

  • The global hospital-acquired infection market is segmented by infection type into Urinary Tract Infections, Ventilator-Associated Pneumonia, Bloodstream Infections, Surgical Site Infections, and Others.

  • Among these, the Urinary Tract Infections hold the largest market share in 2017 with increasing patients undergoing urological manipulations, long-stay elderly male patients, and patients with debilitating diseases. The urinary tract infections segment is also growing at the highest CAGR during the forecast period.

  • Further, based on treatment, the Hospital Acquired Infections (HAI) market is segmented into antibacterial, antiviral, antifungal, and other therapies. Among these, the antibacterial treatment segment accounted for the largest market share in 2017, due to their increased efficiency in hospital-acquired infections.

  • The below graph shows the estimated number of healthcare-associated infections (HAIs) in U.S. acute care hospitals in 2011. Based on a survey, it was determined that around 722 thousand HAIs occurred in U.S hospitals in 2011.

Clinical Trial Analysis of Hospital Acquired Infections (HAI):

Total No. of Study: 262

Geography Analysis:

  • Geographically, the Hospital Acquired Infections (HAI) market is segmented into North America, Europe, Asia-Pacific, South America, and RoW. North America is dominating the global HAI market due to the growing development of new therapeutic procedures in bacterial infections.

Competitive Landscape:

  • The global Hospital Acquired Infections (HAI) market is highly consolidated with few companies accounting for the majority of the market share.

  • Companies are highly investing in R & D and are collaborating with other companies for developing products.
    Some of the major companies in the global Hospital Acquired Infections (HAI)market include 3M, Advanced Sterilization Products, Becton Dickinson and Company, STERIS Corp., Getinge AB, Cantel Medical Corp., Belimed AG, Abbott Laboratories, Pfizer Inc., and Bayer AG.

  • Some of the recent development contributing to the growth of the global Hospital Acquired Infections market are:
    • In March 2017, Pfizer Launches Zavicefta™ (ceftazidime-avibactam) in the U.K. and Germany, a New Antibiotic to Treat Complicated Infections Caused by Gram-Negative Bacteria.
    • In May 2018, PCT Ltd, formerly Bingham Canyon Corporation, a leading provider of cleaning and disinfecting solutions, introduced its Annihilyzer® Infection Control System that is designed to help alleviate the growing problems of Hospital Acquired Infections (HAI’s).

Key Market Segments

Infection Type

• Urinary Tract Infections
• Ventilator-Associated Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Others

Treatment Type

• Antibacterial Treatment
• Antiviral Treatment
• Antifungal Treatment
• Others

Research Scope

• Hospital Acquired Infections (HAI)Market Value
• Hospital Acquired Infections (HAI)Market Share by Geography and Product type
• Hospital Acquired Infections (HAI)Epidemiology
• Hospital Acquired Infections (HAI)Product Analysis

Trending Topics

Clinical Microbiology Market

Surgical Glue Market

Disposable Syringes Market


What is the Hospital Acquired Infections Market growth?

The market is growing at a High CAGR

What is Hospital Acquired Infections Market size in 2021

The Hospital Acquired Infections Market size was valued at USD YY million in 2021

Who are the key players in Hospital Acquired Infections Market ?

Hospital Acquired Infections (HAI)market include 3M, Advanced Sterilization Products, Becton Dickinson and Company, STERIS Corp

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!